Moscow/New Delhi, December 01, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) today announced the Russian single-component Sputnik Light vaccine against coronavirus has been approved in Lao People’s Democratic Republic. Thus Laos has become the 20th country to register Sputnik Light.
Sputnik Light vaccine is based on human adenovirus serotype 26, which is the first component of the Sputnik V vaccine. In March 2021 the two-dose Sputnik V was also authorized in Laos. Both Sputnik Light and Sputnik V vaccines have been approved under the emergency use authorization procedure.
One-shot Sputnik Light is a highly effective vaccine when used both on standalone basis and applied as a booster. The latest findings by the Gamaleya Center based on data from 28,000 subjects in Moscow have demonstrated Sputnik Light vaccine administered standalone has 70% efficacy against infection from the Delta variant of coronavirus during the first three months after vaccination. The vaccine is 75% effective among subjects under the age of 60.
Efficacy of one-shot Sputnik Light as a booster against Delta variant for other vaccines will be close to the efficacy against the Delta variant of the Sputnik V vaccine: over 83% against infection and over 94% against hospitalization.
A one-shot vaccination regimen of Sputnik Light has a number of key advantages, including ease of administering the vaccine, monitoring and more flexible re-vaccination schedule when used as a booster.
Sputnik Light has demonstrated a superior efficacy compared with some two-shot vaccines, which have shown a major decline in efficacy against the Delta variant to less than 50% five months after injection. Standalone use of Sputnik Light also provides much higher efficacy against severe disease and hospitalizations.
Sputnik Light has been proven to be safe and highly effective by real-world vaccination data. In particular, the vaccine has demonstrated efficacy of between 78.6-83.7% among the elderly as confirmed by the Ministry of Health of Buenos Aires, Argentina. Paraguay’s Ministry of Health also found Sputnik Light to be 93.5% effective during the country’s ongoing vaccination campaign.
Russian Direct Investment Fund (RDIF) is Russia's sovereign wealth fund established in 2011 to make equity co-investments, primarily in Russia, alongside reputable international financial and strategic investors. RDIF acts as a catalyst for direct investment in the Russian economy. RDIF’s management company is based in Moscow.
Currently, RDIF has experience of the successful joint implementation of more than 80 projects with foreign partners totaling RUB 2.1tn and covering 95% of the regions of the Russian Federation. RDIF portfolio companies employ more than 1 mn people and generate revenues which equate to more than 6% of Russia’s GDP. RDIF has established joint strategic partnerships with leading international co-investors from more than 18 countries that total more than $40 bn. Further information can be found at rdif.ru
*This Press Release is published by team VOH*
Mankind Pharma partners with NOTTO to create awareness around World Organ Donati
Stanplus and Narayana Hrudayalaya Team Up to Take Emergency Care and Ambulance S
Easing the Burden of Surgery for the Underprivileged
Medical Cannabis startup HempStreet announces partnership with Amrita School of
NCR to Get India's Largest Private Sector Hospital with Amrita Hospital Faridaba
Eyeing Bigger Horizons: Dr Agarwals Eye Hospitals Acquires Five Eye Hospitals in
HiGenoMB®- HiMedia Proudly Announces CE-IVD Approval Received for Hi-PCR®COVID
Pfizer India and Max Hospitals partner to create Fellowship Programme to amplify
Connected beds in non-ICU hospital wards can save over INR 2150 Cr per year for
Fitterfly Becomes Amazon Sambhav Ventures First Healthtech Investment with $12MN
CONNECTED HEALTHTEC DISRUPTOR EKA CARE RAISES $15Mn IN FUNDING
MediBuddy takes over Healthtech Startup Clinix to amplify rural reach
MFine and LifeCell’s diagnostic arm raises $80Mn to disrupt the digital health
Fortis Brings Together Patients Recovered from Heart Surgeries, Shares Stories o
ISA and QAI Inks MOU to Strengthen Stroke Care Across the CountryView All